EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development

Alexandra H Mandarano, Tarsha L Harris, Blaine M Creasy, Marie Wehenkel, Marygrace Duggar, Benjamin A Wilander, Ashutosh Mishra, Jeremy Chase Crawford, Sarah A Mullen, Katherine M Williams, Meenu Pillai, Anthony A High und 1 weitere

Cell Reports · 2023

DOI: 10.1016/j.celrep.2023.112106 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2023. Verfasst von Alexandra H Mandarano und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Autoimmune Diseases. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, Juvenile Diabetes Research Foundation International.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1Autoimmune DiseasesMiceAnimalsInterleukin-2Protein Serine-Threonine KinasesT-Lymphocytes, RegulatoryMice, Inbred NOD

Stichwörter der Autor:innen

CP: ImmunologyIL-2T cellsregulatory T cellsthymustolerancetype 1 diabetes

Substanzen

Interleukin-2Protein Serine-Threonine KinasesDrak2 protein, mouse

Autor:innen und Institutionen

  • Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA; St. Jude Graduate School of Biomedical Sciences, Memphis, TN 38105, USA.
  • Center for Proteomics and Metabolomics, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. Electronic address: maureen.mcgargill@stjude.org.

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • Juvenile Diabetes Research Foundation International
  • JDRF
  • National Institutes of Health
  • American Lebanese Syrian Associated Charities
  • National Cancer Institute

Zitieren

APA

Mandarano, A. H., Harris, T. L., Creasy, B. M., Wehenkel, M., Duggar, M., Wilander, B. A., Mishra, A., Crawford, J. C., Mullen, S. A., Williams, K. M., Pillai, M., High, A. A., & McGargill, M. A. (2023). DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development. Cell Reports. https://doi.org/10.1016/j.celrep.2023.112106

Vancouver

Mandarano AH, Harris TL, Creasy BM, Wehenkel M, Duggar M, Wilander BA, et al. DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development. Cell Reports. 2023. doi:10.1016/j.celrep.2023.112106

BibTeX
@article{Mandarano2023,
  author = {Mandarano, Alexandra H and Harris, Tarsha L and Creasy, Blaine M and Wehenkel, Marie and Duggar, Marygrace and Wilander, Benjamin A and Mishra, Ashutosh and Crawford, Jeremy Chase and Mullen, Sarah A and Williams, Katherine M and Pillai, Meenu and High, Anthony A and McGargill, Maureen A},
  title = {DRAK2 contributes to type 1 diabetes by negatively regulating IL-2 sensitivity to alter regulatory T cell development},
  journal = {Cell Reports},
  year = {2023},
  doi = {10.1016/j.celrep.2023.112106}
}
Kostenlos starten →